Tranexamic acid and fibrinolytic activity of the vessel wall.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects* / Q000502:physiology; D003331:Coronary Vessels / Q000187:drug effects; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology*; D005342:Fibrinolysis / Q000187:drug effects*; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D010958:Plasminogen / Q000502:physiology; D051381:Rats
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines; D010958:Plasminogen